| # | Title | Journal | Year | Citations |
|---|
| 1 | Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal | Oxidative Medicine and Cellular Longevity | 2014 | 3,650 |
| 2 | Plant Polyphenols as Dietary Antioxidants in Human Health and Disease | Oxidative Medicine and Cellular Longevity | 2009 | 3,187 |
| 3 | Oxidative Stress: Harms and Benefits for Human Health | Oxidative Medicine and Cellular Longevity | 2017 | 2,095 |
| 4 | ROS and ROS-Mediated Cellular Signaling | Oxidative Medicine and Cellular Longevity | 2016 | 1,224 |
| 5 | Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? | Oxidative Medicine and Cellular Longevity | 2016 | 1,221 |
| 6 | The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults | Oxidative Medicine and Cellular Longevity | 2016 | 976 |
| 7 | Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis | Oxidative Medicine and Cellular Longevity | 2019 | 947 |
| 8 | Role of ROS and RNS Sources in Physiological and Pathological Conditions | Oxidative Medicine and Cellular Longevity | 2016 | 915 |
| 9 | Role of Glutathione in Cancer Progression and Chemoresistance | Oxidative Medicine and Cellular Longevity | 2013 | 886 |
| 10 | Achieving the Balance between ROS and Antioxidants: When to Use the Synthetic Antioxidants | Oxidative Medicine and Cellular Longevity | 2013 | 849 |
| 11 | Exogenous Antioxidants—Double-Edged Swords in Cellular Redox State: Health Beneficial Effects at Physiologic Doses versus Deleterious Effects at High Doses | Oxidative Medicine and Cellular Longevity | 2010 | 804 |
| 12 | Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox? | Oxidative Medicine and Cellular Longevity | 2016 | 725 |
| 13 | Mechanism of Oxidative Stress in Neurodegeneration | Oxidative Medicine and Cellular Longevity | 2012 | 680 |
| 14 | ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age-Related Diseases | Oxidative Medicine and Cellular Longevity | 2016 | 661 |
| 15 | Antioxidant Systems and Oxidative Stress in the Testes | Oxidative Medicine and Cellular Longevity | 2008 | 570 |
| 16 | Oxidative Stress and the Pathogenesis of Alzheimer's Disease | Oxidative Medicine and Cellular Longevity | 2013 | 568 |
| 17 | Role of Antioxidants and Natural Products in Inflammation | Oxidative Medicine and Cellular Longevity | 2016 | 559 |
| 18 | Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications | Oxidative Medicine and Cellular Longevity | 2017 | 519 |
| 19 | Properties of Resveratrol:In VitroandIn VivoStudies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans | Oxidative Medicine and Cellular Longevity | 2015 | 510 |
| 20 | Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans | Oxidative Medicine and Cellular Longevity | 2017 | 510 |
| 21 | ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells | Oxidative Medicine and Cellular Longevity | 2019 | 496 |
| 22 | Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF | Oxidative Medicine and Cellular Longevity | 2015 | 486 |
| 23 | Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases | Oxidative Medicine and Cellular Longevity | 2019 | 478 |
| 24 | Honey, Propolis, and Royal Jelly: A Comprehensive Review of Their Biological Actions and Health Benefits | Oxidative Medicine and Cellular Longevity | 2017 | 476 |
| 25 | Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease | Oxidative Medicine and Cellular Longevity | 2018 | 447 |
| 26 | Structural, Chemical and Biological Aspects of Antioxidants for Strategies Against Metal and Metalloid Exposure | Oxidative Medicine and Cellular Longevity | 2009 | 445 |
| 27 | Caspase-3 Deletion Promotes Necrosis in Atherosclerotic Plaques of ApoE Knockout Mice | Oxidative Medicine and Cellular Longevity | 2016 | 428 |
| 28 | Redox Regulation in Cancer: A Double-edged Sword with Therapeutic Potential | Oxidative Medicine and Cellular Longevity | 2010 | 409 |
| 29 | The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases | Oxidative Medicine and Cellular Longevity | 2016 | 406 |
| 30 | Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies | Oxidative Medicine and Cellular Longevity | 2017 | 392 |
| 31 | Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development | Oxidative Medicine and Cellular Longevity | 2019 | 390 |
| 32 | Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease | Oxidative Medicine and Cellular Longevity | 2019 | 388 |
| 33 | Oxidative Stress and Anxiety: Relationship and Cellular Pathways | Oxidative Medicine and Cellular Longevity | 2009 | 384 |
| 34 | Cadmium and Its Neurotoxic Effects | Oxidative Medicine and Cellular Longevity | 2013 | 377 |
| 35 | Reviews on Mechanisms ofIn VitroAntioxidant Activity of Polysaccharides | Oxidative Medicine and Cellular Longevity | 2016 | 374 |
| 36 | Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation | Oxidative Medicine and Cellular Longevity | 2019 | 369 |
| 37 | ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury | Oxidative Medicine and Cellular Longevity | 2016 | 365 |
| 38 | The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease: A Mini Review | Oxidative Medicine and Cellular Longevity | 2016 | 363 |
| 39 | Markers of Oxidative Stress in Erythrocytes and Plasma During Aging in Humans | Oxidative Medicine and Cellular Longevity | 2010 | 335 |
| 40 | Mechanisms of Neuroprotection by Quercetin: Counteracting Oxidative Stress and More | Oxidative Medicine and Cellular Longevity | 2016 | 326 |
| 41 | Exercise Modifies the Gut Microbiota with Positive Health Effects | Oxidative Medicine and Cellular Longevity | 2017 | 326 |
| 42 | Diabetes and the Brain: Oxidative Stress, Inflammation, and Autophagy | Oxidative Medicine and Cellular Longevity | 2014 | 325 |
| 43 | Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases | Oxidative Medicine and Cellular Longevity | 2013 | 324 |
| 44 | Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus | Oxidative Medicine and Cellular Longevity | 2020 | 323 |
| 45 | Free Radical Damage in Ischemia-Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization Therapy | Oxidative Medicine and Cellular Longevity | 2018 | 313 |
| 46 | Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View | Oxidative Medicine and Cellular Longevity | 2019 | 311 |
| 47 | PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism | Oxidative Medicine and Cellular Longevity | 2020 | 302 |
| 48 | Hydroxyl Radical and Its Scavengers in Health and Disease | Oxidative Medicine and Cellular Longevity | 2011 | 299 |
| 49 | Neuroprotective Function of DJ-1 in Parkinson’s Disease | Oxidative Medicine and Cellular Longevity | 2013 | 299 |
| 50 | Advanced Glycation end Products, Oxidative Stress and Diabetic Nephropathy | Oxidative Medicine and Cellular Longevity | 2010 | 298 |
